Clinical Trials in Arizona

Showing 15821-15840 of 16,770 trials

Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid Tumors

NCT01151384

Liposome Encapsulated Docetaxel (LE-DT) is a novel proprietary delivery system of docetaxel developed by NeoPharm, Inc. In this Phase I study, the LE-DT was evaluated for the maximum tolerated dose and dose limiting toxicity (DLT) in patients with advance solid tumors. It was also evaluated for pharmacokinetic and anti-tumor effects.

Solid Tumors

INSYS Therapeutics Inc30 participantsStarted Feb 2008

Scottsdale, Arizona, United States • Washington D.C., District of Columbia, United States

COMPLETEDPhase 342 miles

Evaluation of Diagnostic HIV Ag/Ab Combo Assay

NCT00933933

To test blood specimens using a new investigational test that detects antigen and antibody to human immunodeficiency virus (HIV). Results will be compared to an approved HIV antibody test and supplemental testing performed to determine HIV status.

Human Immunodeficiency Viruses

Abbott Diagnostics Division635 participantsStarted Jun 2009

Phoenix, Arizona, United States • St. Petersburg, Florida, United States • Springfield, Illinois, United States +10 more locations

Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid Tumors

Evaluation of Diagnostic HIV Ag/Ab Combo Assay

Find Trials by Condition in Arizona

Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa

Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis

A Multiple Myeloma Trial in Patients With Bone Metastases

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Double-Blind, Multicenter, Study Comparing the Efficacy and Safety of OMS103HP With Vehicle Irrigation Solution in Subjects Undergoing Meniscectomy

Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer

A Study for Patients With Type 2 Diabetes Mellitus

Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC

Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease

A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse

A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI

A Phase 1-2, Multicenter, Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas

A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.

IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

A Prospective Study to Evaluate the Safety of a New Monovalent Intranasal Influenza Vaccine

A Clinical Study to Assess the Safety of a New Influenza Vaccine

A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer